NOVEMBER 2025 I MAZE THERAPEUTICS
American Society of Nephrology Kidney Week | Sheela Crasta et al.Small Molecule Inhibitors of APOL1 Reverse Dysfunctional Signaling Mediated by APOL1 Risk Variants in Immortalized Human Podocytes
Small Molecule Inhibitors of APOL1 Reverse Dysfunctional Signaling Mediated by APOL1 Risk Variants in Immortalized Human Podocytes